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Viral RCAMurine gammaherpesvirus-68 (MHV68) is genetically related to human Epstein–Barr virus and Kaposi's
sarcoma-associated herpesvirus and provides a tractable model to study gammaherpesvirus–host
interactions in vivo and in vitro. The MHV68-encoded v-RCA product inhibits murine complement activation
and shares sequence homology with other virus and host regulators of complement activation. Here we
show that v-RCA is required for efﬁcient MHV68 replication in primary murine macrophages, but not in
murine embryonic ﬁbroblasts. v-RCA-deﬁcient MHV68 mutant viruses display defects in viral DNA synthesis
in infected macrophages. Importantly, attenuated growth of v-RCA mutant viruses is not rescued in
macrophages lacking critical components of the complement system including C3, indicating that the
macrophage-speciﬁc role of v-RCA in MHV68 replication is complement-independent. This contrasts with
the situation in vivo in which attenuated neurovirulence of v-RCA mutant viruses is rescued in C3-deﬁcient
mice. This study shows a novel, complement independent cell-type-speciﬁc function of a gammaherpesvirus
RCA protein.
© 2009 Elsevier Inc. All rights reserved.Introduction
Murine gammaherpesvirus-68 (MHV68, γHV68) is a rodent
gammaherpesvirus genetically and biologically related to human
gammaherpesviruses Epstein–Barr virus (EBV), Kaposi's sarcoma-
associated herpesvirus (KSHV), and simian herpesvirus saimirii (HVS)
(Efstathiou et al., 1990a; Virgin et al., 1997). In vivo, MHV68
establishes latency in a variety of cell types, including macrophages,
B cells, and dendritic cells (Flano et al., 2000; Sunil- Chandra et al.,
1992; Weck et al., 1999a, 1999b; Willer and Speck, 2003). There are
several lines of evidence indicating that MHV68–host interactions are
determined by cell-type speciﬁc functions of viral genes. During the
establishment of latency, expression of viral genes is dependent on
cell type and stage of cell differentiation (Marques et al., 2003).
Further, MHV68-encoded proteins, such as M2 and v-cyclin, display
cell-type speciﬁc effects in vitro and during latency in vivo
(Herskowitz et al., 2005, 2008; Van Dyk et al., 2003; Siegel et al.,
2008). The MHV68-encoded protein kinase orf36 is required for
efﬁcient MHV68 replication in primary bone marrow derived
macrophages, but not mouse embryonic ﬁbroblasts (MEFs) in vitrocontacted at Department of
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ll rights reserved.(Tarakanova et al., 2007). From the host perspective, several cellular
signaling pathways, such as NF-kB and interferon gamma signaling,
function in a cell-type speciﬁc manner during MHV68 latency (Krug
et al., 2007; Steed et al., 2007). Therefore, determining the cell type-
speciﬁc activities of MHV68 genes in relevant primary cells such as
macrophages is an important goal for linking studies of viral gene
function to studies of the pathogenesis of infection (Virgin, 2007).
The MHV68 v-RCA protein is homologous to host and virus RCA
proteins encoded by other herpes as well as poxviruses (Cummings
et al., 2007; Kapadia et al., 1999, 2002). Both host and viral
homologues of the MHV68 v-RCA protein inhibit the classical and
alternative pathways of complement activation by multiple
mechanisms, including accelerated decay of C3 convertase, degra-
dation of activated complement factors, and prevention of comple-
ment deposition (Cummings et al., 2007). Importantly, not all
activities of this class of viral molecules are complement dependent.
Vaccinia-encoded RCA protein (B5R), in addition to its complement
regulatory functions, plays a role in virion morphogenesis, cell-to-
cell spread, and induction of thick actin bundles in vitro (Herrera
et al., 1998; Mathew et al., 2001; Rodger and Smith, 2002). Vaccinia
complement-control protein (VCP), KSHV KCP, as well as cellular C4b
binding protein and factor H also bind heparan sulfate proteoglycans,
suggesting a potential role for viral RCA proteins in viral binding and
entry (Mark et al., 2006; Mullick et al., 2005; Murthy et al., 2001;
Blackmore et al., 1998; Prodinger et al., 1998; Blom et al., 2001).
Together these data indicate that viral RCA proteins can have com-
plement independent roles in infection.
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for MHV68 growth in a mouse ﬁbroblast cell line (Kapadia et al.,
1999). Recombinant v-RCA and supernatants from MHV68 infected
cells are sufﬁcient to block complement deposition on zymosan beads
(Kapadia et al., 1999). In vivo, absence of MHV68 v-RCA leads to a
modest attenuation of acute viral replication in adult BL6 mice,
However, v-RCA has an important role in neurovirulence of MHV68 in
weanling CD-1 mice (Kapadia et al., 2002). CD-1 mice infected with a
MHV68 mutant lacking v-RCA show decreased viral titers in
numerous organs and increased survival as compared to wild type
MHV68 infected mice (Kapadia et al., 2002). The virulence of v-RCA
mutant virus in weanling mice is rescued in mice deﬁcient in C3, a
critical component of all pathways of complement activation (Kapadia
et al., 2002). These data show that a major aspect of v-RCA function
relates to inhibition of C3-dependent actions of complement in vivo.
However, there are other in vivo phenotypes of v-RCA mutant virus
where the role of complement has not been determined. For example,
the lethality of v-RCA mutant virus is attenuated in interferon γ
receptor deﬁcient mice (Kapadia et al., 2002). It is not clear whether
complement plays a role in this attenuation. While complement
controls reactivation of wild type MHV68 from latency, v-RCA also
seems to be dispensable for MHV68 reactivation from latency in BL6
and C3−/−mice (Kapadia et al., 2002). These considerations led us to
test the hypothesis that MHV68 v-RCA has complement independent
effects relevant to viral replication. We focused on the possible role of
v-RCA in primary macrophages as these cells harbor latent MHV68.
Results and discussion
MHV68 v-RCA is required for efﬁcient viral replication in macrophages
We previously found a MHV68 gene (orf36) required for viral
replication in cultured primary macrophages but not embryonic
ﬁbroblasts (Tarakanova et al., 2007). This suggested that assays
performed in ﬁbroblasts may not provide information on the relevant
functions of MHV68 genes, a ﬁnding conﬁrmed by recent studies
demonstrating a role for the MHV68 v-cyclin in primary endothelial
cells (Suarez and Van Dyk, 2008). To identify otherMHV68 genes with
cell-type speciﬁc requirements during viral replication, a panel of
MHV68 mutants was examined for growth defects in primary bone
marrow derived macrophages. Attenuated replication was observed,
at both high and low multiplicities of infection, for a mutant virus
containing a translational stop in v-RCA [RCAstop (Kapadia et al.,
2002)] (Fig. 1A and data not shown). We conﬁrmed that mutation of
v-RCA had no effect on replication in mouse embryonic ﬁbroblasts
(Fig. 1B). The RCAstop MHV68 mutant was derived from wild type
virus by insertion of two stop codons and a frame shift in the v-RCA
open reading frame, and eliminates expression of v-RCA in a mouse
ﬁbroblast cell line (Kapadia et al., 2002).
To conﬁrm that the defect in growth in macrophages observed in
RCAstop is due to the altered open reading frame and not a secondary
effect of the particular mutation in v-RCA, we tested a second
independently constructed v-RCA mutant generated by transposon
insertion at a site distinct from the translational stop present in the
RCAstop MHV68 mutant (Song et al., 2005). Compared to the control
virus (STM BAC), growth of orf4 null was attenuated in macrophages
(Fig. 1C). The consistency of phenotype between two v-RCA mutant
viruses constructed independently strongly suggests that the pheno-
type of decreased growth in primary macrophages is due to mutation
of orf4 encoding v-RCA.
In MHV68-infected 3T12 ﬁbroblast cells, v-RCA protein is
associated with the surface of infected cells and the virion envelope
(Kapadia et al., 1999). As v-RCA is not essential for efﬁcient growth of
the virus in those cells, we considered the possibility that the sub-
cellular distribution of v-RCA might differ between infected ﬁbro-
blasts and macrophages. V-RCA staining in MHV68-infected macro-phages was consistent with the endoplasmic reticulum and plasma
membrane localization, suggesting that the subcellular distribution of
v-RCA was similar in primary macrophages and ﬁbroblasts [Fig. 1D,
(Kapadia et al., 1999)]. As expected, no v-RCA speciﬁc staining was
detected in mock-infected or RCAstop-infected primary macrophages
(Fig. 1D).
V-RCA is expressed with late kinetics in primary MHV68-infected
macrophages
V-RCA is classiﬁed as a late viral protein based on its expression in
3T12 ﬁbroblasts (Kapadia et al., 1999). To determine if this is correct
in primary macrophages we performed western analysis to deﬁne the
kinetics and transcriptional class of v-RCA expression inmacrophages.
v-RCA was undetectable in MHV-68 infected primary macrophages at
24 h post-infection, but accumulated by 48 h post-infection (Fig. 2A).
As expected, mutation of orf4 eliminated v-RCA expression (Fig. 2A).
When primary MHV-68 infected macrophages were treated with
cidofovir, v-RCA expression was no longer detected at 48 h post-
infection as compared to untreated controls (Fig. 2B, compare ﬁrst
two lanes). In addition to its effect on v-RCA expression, cidofovir
treatment led to a reduction in expression levels of several MHV68
proteins detected by the polyclonal anti-MHV68 antibody [Fig. 2B,
(Dal Canto et al., 2000)]. Thus, similar to ﬁbroblasts, v-RCA was
expressed with late kinetics in MHV68-infected primary
macrophages.
MHV68 v-RCA is required for viral DNA synthesis in infected
macrophages
Host and viral RCA proteins interact with heparan sulfate
proteoglycans with a proposed effect on virus binding (Mark et al.,
2006; Mullick et al., 2005; Murthy et al., 2001; Blackmore et al., 1998;
Prodinger et al., 1998; Blom et al., 2001). Furthermore, human
herpesvirus-6 and EBV utilize host RCA proteins or complement
receptors for cell entry (Santoro et al., 1999; Fingeroth et al., 1988).
MHV68 v-RCA protein is an envelope component of MHV68 virions
(Kapadia et al., 1999), raising the possibility that attenuation of v-RCA
MHV68mutants in primary macrophages (Figs. 1A, C) could be due to
defects early in infection. To address whether v-RCA is required early
in MHV68 infection, levels of several viral transcripts were measured
in primary macrophages infected with v-RCA deﬁcient or wild type
MHV68. Measured viral transcripts encode proteins critical for
MHV68 DNA synthesis, lytic replication, or cell type-speciﬁc replica-
tion in macrophages (Table 1, Fig. 2C). The kinetic class of examined
MHV-68 transcripts had been deﬁned (Martinez-Guzman et al.,
2003).
Total RNA isolated from primary macrophages infected with wild
type MHV68 or RCAstop mutant for 17 h was subjected to qRT-PCR
analysis. All transcripts examined, including transcripts from the
immediate early and early transcriptional classes, were expressed
comparably between RCAstop- and wild type-infected cells (Fig. 2C).
Similar results were observed with the orf4 null mutant (data not
shown). Comparable levels of immediate early and early viral
transcripts in cells infected with control and v-RCA mutant viruses
indicates that v-RCA does not play a signiﬁcant role in cell entry,
transport of the viral genome to the nucleus, or the initial stages of
MHV68 gene expression.
We next considered the hypothesis that v-RCA is important for
viral DNA synthesis. Total DNA was harvested from primary
macrophages infected with STM BAC or orf4 null MHV68 mutant at
several times post-infection and subjected to Southern analysis using
viral genome as a probe. Signal from the EcoRI H fragment (Efstathiou
et al., 1990b) was measured over multiple experiments and the
results pooled for analysis (Fig. 2D). Levels of MHV68 DNA were
similar at 16 and 25 h post-infection in macrophages infected with
Fig. 1.MHV68 v-RCA is required for efﬁcient viral replication in primary bone marrow derived macrophages. Primary mouse macrophages (A, C) or mouse embryonic ﬁbroblasts (B)
were infected with 10 PFU/cell of v-RCA-deﬁcient mutants or control wild type viruses in triplicate, samples were harvested at indicated time points and titered on BALB-3T12. (D)
Primary macrophages were mock-infected or infected with 5 PFU/cell of indicated viruses and stained at 48 h post-infection with anti-v-RCA and DAPI to visualize nuclei. Shown is a
representative result of at least three independent experiments.
325V.L. Tarakanova et al. / Virology 396 (2010) 323–328STM BAC or orf4 null viruses (Fig. 2D, pN0.05). These results are
consistent with v-RCA-independent expression of early viral genes
(17 h post-infection, Fig. 2C), suggesting that v-RCA is dispensable for
early events in MHV68 infection of primary macrophages. However,
MHV68 DNA accumulation was signiﬁcantly reduced at 48 h post-
infection in macrophages infected with orf4 null MHV68 mutant as
compared to the control STM BAC virus (Fig. 2D, pb0.01), indicating
that vRCA is required for efﬁcient MHV68 DNA synthesis in primary
macrophages.
Complement component expression is not required for v-RCA-dependent
MHV68 replication in primary macrophages
MHV68 v-RCA protein inhibits complement activation at the level
or upstream of C3 in the complement cascade (Kapadia et al., 1999).
Further, macrophages can express most if not all of the proteins in the
complement system, including C3, in addition to multiple comple-
ment regulatory proteins (Morgan and Gasque, 1997). Therefore, we
tested the hypothesis that v-RCA is required to counter an antiviral
effect of C3 expression, or complement activation, in primarymacrophage cultures. Macrophages were derived from mice deﬁcient
in C3 or in Factor B, a critical component of an alternative complement
pathway, and infected with wild type MHV68 or the RCAstop virus
mutant (Matsumoto et al., 1997; Circolo et al., 1999). We examined
factor B as a likely candidate for C3 activation in primary macrophage
cultures since these cultures were not expected to contain antibodies
capable of activation of the classical pathway of complement
activation. Deletion of either Factor B or C3 failed to rescue the
attenuated phenotype of MHV68 v-RCA mutant viruses (Fig. 3A).
Identical results were obtained with the orf4 null mutant (data not
shown). These results indicate that v-RCA has a C3 and Factor B
independent function in MHV68 replication in primary macrophages.
Viral RCA, including MHV68 orf4, share homology with host RCA
proteins, such as decay accelerating factor (DAF), complement
receptors 1 and 2 (CR1, CR2), and membrane cofactor protein
(MCP) (Kapadia et al., 1999). Each of the host RCA has a distinct
function in the control of complement activity [reviewed in (Kim and
Song, 2006)]. DAF prevents formation and accelerates decay of
preexisting C3 and C5 convertases. MCP controls C3 activation by
facilitating C3b cleavage. CR1 controls complement activity by
Fig. 2.MHV68 v-RCA is expressed with late kinetics and is required for viral DNA synthesis in infected macrophages. (A, B) Primary macrophages were infected at 10 PFU/cell with
indicated viruses, cellular lysates collected at indicated times post-infection and analyzed by Western. Some of infected cells in B were treated with 1 microgram/ml of cidofovir for
the duration of infection. (C) Total RNA was harvested from primary macrophages infected at 5 PFU/cell for 17 h and treated with DNase. Levels of indicated viral messages and host
GAPDH were measured by qRT-PCR. Viral messages were normalized to corresponding GAPDH levels using delta-delta Ct method. Data was pooled from 2 to 4 independent
experiments for each viral message. The table indicates kinetic class of expression and known functions of proteins encoded by measured viral transcripts. (D) Primarymacrophages
were infected at 5 PFU/cell and total DNA harvested from identical number of infected cells at indicated time points. Levels of MHV68 DNA (EcoRI H fragment) were measured by
Southern using viral genome as a probe. Data were pooled from at least three independent experiments.
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the expression and genetic organization of RCA in human and mouse.
The DAF gene is duplicated in mice (daf-1, daf-2) with ubiquitous
expression of daf-1 and testis-speciﬁc expression of daf-2 (Kim and
Song, 2006). CR1 and 2 are expressed from a single mouse gene
through alternative splicing. MCP is not expressed by somatic cells ofTable 1
qRT-PCR primers.
Viral
gene
Forward primer Reverse primer
Gene 6 GTTGCCAGATATCCCTAGGATGA ACCTGGCTGGGTCAAGAGACT
Orf 59 TGACTGGCAGGTTTTTGTATGC GATGATCGTGAGGCCAATGG
Orf 40 CTGCATTTTATCTCCACACAAAGC TCAGTTGTAGTATGTCACACAGTTCCA
Orf 9 TGCATGCAAGTTTGTCCAGTCT CTTCCCCCAGTTACTCATTGTTTG
Orf 50 AGAAACCCACAGCTCGCACTT CAATATGCTGGACAGGCGTATC
Orf 36 AGCAGCAACATCCACATTCC AACTGCTGCCGTACCAAACA
Orf 56 TGTCTGACTCATCAACACAGAACAA GCATTGACTCATAAGTGTTGCAGTT
GAPDH TGCCCCCATGTTTGTGATG TGTGGTCATGAGCCCTTCCthe mouse, and complement activation is instead controlled by a
functional homologue complement-receptor 1-related gene/protein
Y (Crry) (Foley et al., 1993). Unlike DAF and CR1/2, Crry is critical for
embryonic survival (Xu et al., 2000).
We considered the hypothesis that the host RCA proteins might be
involved in control of the replication of v-RCA mutant viruses. To
examinewhether host RCA proteins play a role in the attenuation of v-
RCA deﬁcient MHV68mutants, macrophages were isolated frommice
deﬁcient in CR1/2 or DAF (Molina et al., 1996; Sun et al., 1999). The
absence of host CR1/2 or DAF failed to rescue the defect in replication
of RCAstop MHV68 mutant (Figs. 3B, C), suggesting that host RCA are
dispensable for v-RCA function in MHV68 replication. Therefore, v-
RCA requirement for efﬁcient MHV68 replication in primary macro-
phages is independent of CR1/CR2 and or host RCA proteins.
This study identiﬁes a macrophage-speciﬁc role for a gammaher-
pesvirus RCA protein in viral replication. Importantly, the connection
between MHV68 complement regulatory protein and MHV68 repli-
cation was established in a primary, physiologically relevant cell type.
While the absence of v-RCA did not affect early phases of MHV68
Fig. 3. Complement system is dispensable for gene 4-dependent MHV68 replication in
primary macrophages. Primary macrophages were isolated from mice with genetic
deﬁciencies in components of complement pathway or RCA proteins. Macrophages
were infected with 5 PFU/cell of wild type MHC68 or RCAstop mutant and virus yield
was determined at indicated times post-infection.
327V.L. Tarakanova et al. / Virology 396 (2010) 323–328infection and did not selectively alter viral release, accumulation of
MHV68 DNA was signiﬁcantly impaired in cells infected with v-RCA
deﬁcient MHV68 mutants. Importantly, the requirement for v-RCA
was independent of C3 and factor B and independent of the known
murine RCA proteins DAF and CR1/2. Together these data suggest that
v-RCA is multifunctional, playing a role in countering the activities of
the classical and alternative C3 convertases under some circum-
stances, while playing a role in viral DNA synthesis in macrophages. In
this respect, it appears that MHV68 has evolved to combine
complement-dependent and complement-independent roles for
proteins containing SCR domains in a single gene product. MHV68
vRCA is homologous to RCA encoded by herpesviruses and poxviruses.
In the future studies it will be important to identify the mechanism of
complement-independent function of MHV68 v-RCA, as it may be
shared with other v-RCA proteins.
Materials and methods
Animals
C57BL/6J (BL6) mice were obtained from Jackson Laboratories
(Bar Harbor, Maine) and bred at Washington University, St. Louis,
MO. C3, Factor B, and CR1/2 deﬁcient mice were provided by Dr.Diamond. DAF deﬁcient mice were provided by Dr. Atkinson. All
mice were housed in a speciﬁc-pathogen-free barrier facility at
Washington University in accordance with federal and institutional
guidelines. Bone marrow was harvested from mice between 7 and
10 weeks of age.
Virus infections and primary bone marrow macrophage derivation
Primary bone marrow macrophages were generated and infected
as previously described (Tarakanova et al., 2007). All samples were
titered on NIH 3T12 ﬁbroblasts.
Western blot analysis
Macrophages or ﬁbroblasts were collected into laemmli buffer and
analyzed as previously described (Lenschow et al., 2005). Antibodies
used were anti-gene 4 (Kapadia et al., 1999) (1:1000 dilution), anti-β
actin (1:3000 dilution, clone AC-74 Sigma, Saint Louis, MO), and a
secondary goat anti-mouse or anti-rabbit HRP-conjugated secondary
antibody (Jackson Immunoresearch).
Immunoﬂuorescence assay
Immunoﬂuorescence assaywas performed as previously described
(Tarakanova et al., 2007). Anti-gene 4 antibody was used at a 1:200
dilution.
Southern analysis
Total DNA was harvested from infected macrophages and 20
micrograms digested overnight with EcoRI. Digested DNA was
electrophoresed through a 0.8% agarose gel in the presence of the
Tris-Acetate-EDTA (TAE) buffer and denatured as follows: 30 min
rinse in 0.2N hydrochloric acid, followed by two 30 min rinses in a
Base solution (1.5 M sodium chloride, 0.5 M sodium hydroxide). DNA
was transferred to a Nylon membrane (Hybond-N+, GE Healthcare,
Piscataway, NJ) overnight using a standard capillary transfer approach
in the presence of a Transfer buffer (3 M sodium chloride, 8 mM
sodium hydroxide). Membrane with DNA was crosslinked by UV
irradiation and blocked in the hybridization buffer (5 × SSC, 1 ×
Denhardt's solution, 10% dextran sulfate, 1% SDS, 50% formamide,
0.1 mg/ml sheared salmon sperm DNA) for 1–2 h at 42 °C. Megaprime
DNA labeling system (GE Healthcare, Piscataway, NJ) was used to
prepare a 32P-labeled probe with BAC MHV68 DNA as a template.
Probe in fresh hybridization buffer was added to the blocked
membrane and hybridization was conducted at 42 °C overnight.
After a quick rinse in the wash buffer (0.1% SDS, 2× SSC ) to remove
most of radioactivity, membrane was washed at 65 °C twice, 15 min
each wash. Signal was detected and quantiﬁed using Storm
phosphorimager (GE Healthcare, Piscataway, NJ).
qRT-PCR quantitation of viral messages
Total RNA was harvested from infected cells using Trizol according
to the manufacturer's instructions (Invitrogen, Carlsbad, CA). Three
micrograms of RNA were treated with RNase free DNAse (Ambion,
Austin, TX) and split into two reactions. First half was subjected to
reverse transcription using SSII Superscript (Invitrogen, Carlsbad, CA)
and oligo-dT primers. Second half of DNase treated RNAwas subjected
to mock reverse transcription in the absence of the enzyme (-RT
control). cDNA was serially diluted (8-fold), including -RT controls
and measured, in triplicate for each dilution, by real time PCR using
iCycler (Bio-Rad, Hercules, CA). Gene speciﬁc cDNA was ampliﬁed
using probes in Table 1. Delta-delta Ct method was used to quantify
relative abundance of each cDNA. Levels of viral messages were
328 V.L. Tarakanova et al. / Virology 396 (2010) 323–328normalized to the corresponding GAPDH levels. Ct values of -RT
controls did not exceed background levels.Acknowledgments
We would like to thank Darren Kreamalmayer for his outstanding
expertise in animal breeding andmembers of the Virgin laboratory for
helpful discussions. We are grateful to James Brien, Michael Diamond,
XiaoboWu, and John Atkinson for help with the complement deﬁcient
mice. H.W.V. was supported by National Institutes of Health (NIH). V.
L.T. is a Leukemia and Lymphoma society fellow. M.G. is supported by
a National Science Foundation Graduate Research Fellowship.References
Blackmore, T.K., Hellwage, J., Sadlon, T.A., Higgs, N., Zipfel, P.F., Ward, H.M., Gordon, D.L.,
1998. Identiﬁcation of the second heparin-binding domain in human complement
factor H. J. Immunol. 160, 3342–3348.
Blom, A.M., Kask, L., Dahlback, B., 2001. Structural requirements for the complement
regulatory activities of C4BP. J. Biol. Chem. 276, 27136–27144.
Circolo, A., Garnier, G., Fukuda, W., Wang, X.F., Hidvegi, T., Szalai, A.J., Briles, D.E.,
Volanakis, J.E., Wetsel, R.A., Colten, H.R., 1999. Genetic disruption of the murine
complement C3 promoter region generates deﬁcient mice with extrahepatic
expression of C3 mRNA. Immunopharmacology 42, 135–149.
Cummings, K.L., Waggoner, S.N., Tacke, R., Hahn, Y.S., 2007. Role of complement in
immune regulation and its exploitation by virus. Viral Immunol. 20, 505–524.
Dal Canto, A.J., Virgin, H.W., Speck, S.H., 2000. Ongoing viral replication is required for
gammaherpesvirus 68-induced vascular damage. J. Virol. 74, 11304–11310.
Efstathiou, S., Ho, Y.M., Hall, S., Styles, C.J., Scott, S.D., Gompels, U.A., 1990a. Murine
herpesvirus 68 is genetically related to the gammaherpesviruses Epstein–Barr virus
and herpesvirus saimiri. J. Gen. Virol. 71, 1365–1372.
Efstathiou, S., Ho, Y.M., Minson, A.C., 1990b. Cloning and molecular characterization of
the murine herpesvirus 68 genome. J. Gen. Virol. 71, 1355–1364.
Fingeroth, J.D., Clabby, M.L., Strominger, J.D., 1988. Characterization of a T-lymphocyte
Epstein-Barr virus/C3d receptor (CD21). J. Virol. 62, 1442–1447.
Flano, E., Husain, S.M., Sample, J.T., Woodland, D.L., Blackman, M.A., 2000. Latent murine
gamma-herpesvirus infection is established in activated B cells, dendritic cells, and
macrophages. J. Immunol. 165, 1074–1081.
Foley, S., Li, B., Dehoff, M., Molina, H., Holers, V.M., 1993. Mouse Crry/p65 is a regulator
of the alternative pathway of complement activation. Eur. J. Immunol. 23,
1381–1384.
Herrera, E., del Mar, L.M., Blasco, R., Isaacs, S.N., 1998. Functional analysis of vaccinia
virus B5R protein: essential role in virus envelopment is independent of a large
portion of the extracellular domain. J. Virol. 72, 294–302.
Herskowitz, J., Jacoby, M.A., Speck, S.H., 2005. The murine gammaherpesvirus 68 M2
gene is required for efﬁcient reactivation from latently infected B cells. J. Virol. 79,
2261–2273.
Herskowitz, J.H., Siegel, A.M., Jacoby, M.A., Speck, S.H., 2008. Systematic mutagenesis of
the murine gammaherpesvirus 68 M2 protein identiﬁes domains important for
chronic infection. J. Virol. 82, 3295–3310.
Kapadia, S.B., Molina, H., van V, B., Speck, S.H., Virgin, H.W., 1999. Murine
gammaherpesvirus 68 encodes a functional regulator of complement activation.
J. Virol. 73, 7658–7670.
Kapadia, S.B., Levine, B., Speck, S.H., Virgin, H.W., 2002. Critical role of complement and
viral evasion of complement in acute, persistent, and latent gamma-herpesvirus
infection. Immunity 17, 143–155.
Kim, D.D., Song, W.C., 2006. Membrane complement regulatory proteins. Clin.
Immunol. 118, 127–136.
Krug, L.T., Moser, J.M., Dickerson, S.M., Speck, S.H., 2007. Inhibition of NF-kB activation
in vivo impairs establishment of gammaherpesvirus latency. PLoS Pathog. 3,
97–118.
Lenschow, D.J., Giannakopoulos, N.V., Gunn, L.J., Johnston, C., O'Guin, A.K., Schmidt, R.E.,
Levine, B., Virgin, H.W., 2005. Identiﬁcation of interferon-stimulated gene 15 as an
antiviral molecule during Sindbis virus infection in vivo. J. Virol. 79, 13974–13983.
Mark, L., Lee, W.H., Spiller, O.B., Villoutreix, B.O., Blom, A.M., 2006. The Kaposi's
sarcoma-associated herpesvirus complement control protein (KCP) binds to
heparin and cell surfaces via positively charged amino acids in CCP1-2. Mol.
Immunol. 43, 1665–1675.Marques, S., Efstathiou, S., Smith, K.G., Haury, M., Simas, J.P., 2003. Selective gene
expression of latent murine gammaherpesvirus 68 in B lymphocytes. J. Virol. 77,
7308–7318.
Martinez-Guzman, D., Rickabaugh, T., Wu, T.T., Brown, H., Cole, S., Song, M.J., Tong, L.,
Sun, R., 2003. Transcription program of murine gammaherpesvirus 68. J. Virol. 77,
10488–10503.
Mathew, E.C., Sanderson, C.M., Hollinshead, R., Smith, G.L., 2001. A mutational analysis
of the vaccinia virus B5R protein. J. Gen. Virol. 82, 1199–1213.
Matsumoto, M., Fukuda, W., Circolo, A., Goellner, J., Strauss-Schoenberger, J., Wang, X.,
Fujita, S., Hidvegi, T., Chaplin, D.D., Colten, H.R., 1997. Abrogation of the alternative
complement pathway by targeted deletion of murine factor B. Proc. Natl. Acad. Sci.
94, 8720–8725.
Molina, H., Holers, V.M., Li, B., Fung, Y., Mariathasan, S., Goellner, J., Strauss-
Schoenberger, J., Karr, R.W., Chaplin, D.D., 1996. Markedly impaired humoral
immune response in mice deﬁcient in complement receptors 1 and 2. Proc. Natl.
Acad. Sci. 93, 3357–3361.
Morgan, B.P., Gasque, P., 1997. Extrahepatic complement biosynthesis: where, when
and why? Clin. Exp. Immunol. 107, 1–7.
Mullick, J., Singh, A.K., Panse, Y., Yadav, V., Bernet, J., Sahu, A., 2005. Identiﬁcation of
functional domains in Kaposica, the complement control protein homolog of
Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8). J. Virol. 79,
5850–5856.
Murthy, K.H.M., Smith, S.A., Ganesh, V.K., Judge, K.W., Mullin, N., Barlow, P.N., Ogata,
C.M., Kotwal, G.J., 2001. Crystal structure of a complement control protein that
regulates both pathways of complement activation and binds heparan sulfate
proteoglycans. Cell 104, 301–311.
Prodinger, W.M., Hellwage, J., Spruth, M., Dierich, M.P., Zipfel, P.F., 1998. The C-terminus
of factor H: monoclonal antibodies inhibit heparin binding and identify epitopes
common to factor H and factor H-related proteins. Biochem. J. 331, 41–47.
Rodger, G., Smith, G.L., 2002. Replacing the SCR domains of vaccinia virus protein B5R
with EGFP causes a reduction in plaque size and actin tail formation but enveloped
virions are still transported to the cell surface. J. Gen. Virol. 83, 323–332.
Santoro, F., Kennedy, P.E., Locatelli, G., Malnati, M.S., Berger, E.A., Lusso, P., 1999. CD46 is
a cellular receptor for human herpesvirus 6. Cell 99, 817–827.
Siegel, A.M., Herskowitz, J.H., Speck, S.H., 2008. The MHV68 M2 protein drives IL-10
dependent B cell proliferation and differentiation. Plos Pathog. 4.
Song, M.J., Hwang, S.M., Wong, W.H., Wu, T.T., Lee, S.M., Liao, H.I., Sun, R., 2005.
Identiﬁcation of viral genes essential for replication of murine gamma-herpesvirus
68 using signature-tagged mutagenesis. Proc. Natl. Acad. Sci. U. S. A. 102,
3805–3810.
Steed, A., Buch, T., Waisman, A., Virgin, H.W., 2007. Interferon gamma blocks {gamma}-
herpesvirus reactivation from latency in a cell type speciﬁc manner. J. Virol. 81,
6134–6140.
Suarez, A.L., Van Dyk, L.F., 2008. Endothelial cells support persistent gammaherpesvirus
68 infection. Plos. Pathog. 4.
Sun, X., Funk, C.D., Deng, C., Sahu, A., Lambris, J.D., Song, W.C., 1999. Role of decay-
accelerating factor in regulating complement activation on the erythrocyte surface
as revealed by gene targeting. Proc. Natl. Acad. Sci. 96, 628–633.
Sunil- Chandra, N.P., Efstathiou, S., Nash, A.A., 1992. Murine gammaherpesvirus 68
establishes a latent infection in mouse B lymphocytes in vivo. J. Gen. Virol. 73,
3275–3279.
Tarakanova, V.L., Leung-Pineda, V., Hwang, S., Yang, C.-W., Matatall, K., Basson, M., Sun,
R., Piwnica-Worms, H., Sleckman, B.P., Virgin, H.W., 2007. Gamma-herpesvirus
kinase actively initiates a DNA damage response by inducing phosphorylation of
H2AX to foster viral replication. Cell Host Microbe 1, 275–286.
Van Dyk, L.F., Virgin, H.W., Speck, S.H., 2003. Maintenance of gammaherpesvirus
latency requires viral cyclin in the absence of B lymphocytes. J. Virol. 77,
5118–5126.
Virgin, H.W., 2007. In vivo veritas: pathogenesis of infection as it actually happens. Nat.
Immunol. 8, 1143–1147.
Virgin, H.W., Latreille, P., Wamsley, P., Hallsworth, K., Weck, K.E., Dal Canto, A.J., Speck,
S.H., 1997. Complete sequence and genomic analysis of murine gammaherpesvirus
68. J. Virol. 71, 5894–5904.
Weck, K.E., Kim, S.S., Virgin, H.W., Speck, S.H., 1999a. B cells regulate murine
gammaherpesvirus 68 latency. J. Virol. 73, 4651–4661.
Weck, K.E., Kim, S.S., Virgin, H.W., Speck, S.H., 1999b. Macrophages are the major
reservoir of latent murine gammaherpesvirus 68 in peritoneal cells. J. Virol. 73,
3273–3283.
Willer, D.O., Speck, S.H., 2003. Long-term latent murine gammaherpesvirus 68 infection
is preferentially found within the surface immunoglobulin D-negative subset of
splenic B cells in vivo. J. Virol. 77, 8310–8321.
Xu, C., Mao, D., Holers, V.M., Palanca, B., Cheng, A.M., Molina, H., 2000. A critical role
for murine complement regulator crry in fetomaternal tolerance. Science 287,
498–501.
